Advanced in Liver Failure

Olivier M. Detry

CHU Liège
Liege, WAL, BE 
Advanced in Liver Failure
CHU Liège
Liege, WAL, BE 
OverviewLocationsClinical Research

Overview

Olivier Detry practices in Liege, Belgium. Mr. Detry is rated as an Advanced expert by MediFind in the treatment of Liver Failure. His top areas of expertise are Alveolar Echinococcosis, Liver Failure, Echinococcosis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 176 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 17 articles and participated in 2 clinical trials in the study of Liver Failure.

Gender
Male

Locations

CHU Liège
Liege, WAL, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization to Accelerate Future Liver Remnant (FLR) Hypertrophy
DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization to Accelerate Future Liver Remnant (FLR) Hypertrophy
Enrollment Status: Unknown
Publish Date: February 03, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
Infusion of Third-party Mesenchymal Stem Cells After Renal or Liver Transplantation. A Phase I-II, Open-label, Clinical Study
Infusion of Third-party Mesenchymal Stem Cells After Renal or Liver Transplantation. A Phase I-II, Open-label, Clinical Study
Enrollment Status: Completed
Publish Date: June 14, 2022
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
Multicenter Phase II Safety and Preliminary Efficacy Study of 2 Dose Regimens of HepaStem in Patients With Acute on Chronic Liver Failure
Multicenter Phase II Safety and Preliminary Efficacy Study of 2 Dose Regimens of HepaStem in Patients With Acute on Chronic Liver Failure
Enrollment Status: Completed
Publish Date: October 14, 2020
Intervention Type: Biological
Study Phase: Phase 2
View 2 Less Clinical Trials

176 Total Publications

Kidney transplant injury associated with brain death is mediated by TNFα, independently of renal innervation.
Kidney transplant injury associated with brain death is mediated by TNFα, independently of renal innervation.
Journal: American journal of physiology. Renal physiology
Published: June 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Detry's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile